1. ALLA AKTIER
  2. NYHETER
  3. PROSTALUND

ProstaLund

Nyheter ProstaLund Nyheter alla bolag

First patients treated with CoreTherm® Concept in Austria

We are pleased to announce that the first five patients with benign prostatic enlargement (BPE) have been successfully treated with the CoreTherm® Concept in Austria. The treatments were performed by MR Prof. Dr. Karl Diehl in Tulln an der Donau.

“We signed the agreement with Prof. Dr. Karl Diehl in May 2024, and it is fantastic news that the first patients have now been successfully treated. This marks an important first step in establishing CoreTherm® in Europe, fully in line with the company’s stated strategy” said Anders Kristensson, CEO of ProstaLund AB.

For further information, please contact:

Anders Kristensson, CEO
Tel. +46 (0) 769 42 12 16
Email: anders.kristensson@prostalund.com

About CoreTherm®

CoreTherm® is a minimally invasive transurethral microwave thermotherapy for benign prostatic enlargement (BPE). The treatment is performed in an outpatient setting under local anaesthesia and takes less than 15 minutes. No general anaesthesia or spinal block is needed. Follow-up data five years after CoreTherm® treatment shows clinical outcomes comparable to those seen after surgery/TURP (transurethral resection of the prostate), but with lower risk of serious complications. For more information visit, www.coretherm.com.

About ProstaLund

ProstaLund AB (publ) is a Swedish medtech company headquartered in Lund that develops and markets innovative products for the treatment of Benign Prostatic Enlargement (BPE). The company has patented the CoreTherm® Concept, a customised thermal treatment for BPE. ProstaLund is listed on Nasdaq First North Growth Market and has approximately 3,600 shareholders. For more information, visit www.prostalund.se. Our press releases are also available to read and download here: www.prostalund.se/pressmeddelanden

Certified Adviser:
Västra Hamnen Corporate Finance AB
Phone: +46 40 200 250
E-mail: ca@vhcorp.se

Attachments

First patients treated with CoreTherm® Concept in Austria

Datum 2024-08-19, kl 13:00
Källa MFN
Bifogade filer
First patients treated with CoreTherm® Concept in Austria
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!